Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Schuppler, J.
Right arrow Articles by Günzel, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Schuppler, J.
Right arrow Articles by Günzel, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal Article

Proliferative liver lesions and sex steroids in rats

J. Schuppler

Research Laboratories, Schering, Berlin/Bergkamen, and Institut für Toxikologie und Pharmakologie, University of Marburg, FRG

R. Schulte-Hermann

Research Laboratories, Schering, Berlin/Bergkamen, and Institut für Toxikologie und Pharmakologie, University of Marburg, FRG

I. Timmermann-Trosiener

Research Laboratories, Schering, Berlin/Bergkamen, and Institut für Toxikologie und Pharmakologie, University of Marburg, FRG

P. Günzel

Research Laboratories, Schering, Berlin/Bergkamen, and Institut für Toxikologie und Pharmakologie, University of Marburg, FRG

In standard two year tumorigenicity studies some gestagens, alone or in combination with an estrogen have been shown to produce proliferative liver lesions (PLL) in rats. Estrogens in general have not produced PLLs; for ethinyl estradiol the situation is equivocal.

The steroids which increase the incidence of PLLs have not been shown to have the characteristics usually associated with classical hepatocarcinogens such as diethylnitrosamine (e.g. negative mutagenicity and cytoxicity, failure to bind covalently to DNA). Therefore, another mechanism must be assumed. A possible explanation is given by the ability demonstrated for a few steroids (mestranol alone or in combination with norethindrone, ethinylestradiol) to promote preneoplastic islands induced by diethylnitrosamine, resulting in an increase in tumor incidence over rats given only the carcinogen. Spontaneous preneoplastic islands in rats occur in various incidence in different strains and we have recently shown that their reaction to steroids-enhanced proliferation-is the same as the effect on preneoplastic islands produced by classical carcinogens. Sex steroids also enhance the growth or normal hepatocytes. It, therefore, seems reasonable to assume that sex steroids produce PLLs by acting on spontaneous preneoplastic lesions and not by the mechanisms usually associated with classical carcinogens.

Extrapolating the incidence of PLLs in rats to a risk in humans may be highly misleading because of different pharmacokinetic patterns. Even in rats treated orally for two years with sex steroids dosed as multiples of the human contraceptive dose, resorption and biovailability may vary by a factor of 10 or more. It is, therefore, inappropriate to state that one sex steroid is more active in the production of PLLs than another, unless the data from pharmacokinetic studies are taken into account.

Available evidence shows that sex steroids act as tumor promotors and enhance the growth of normal hepatocytes. It is extremely doubtful whether a sex steroid producing PLLs in the rat after two years of oral treatment can be classified as an initiating tumorigen for the rat. Substantial risk for humans cannot be inferred, because of the high incidence of spontaneous preneoplastic lesions in rats, and because of the very high sensitivity of the rat liver to a variety of chemically unrelated compounds including sex steroids.

  • 1. Baum JK, Holtz F, Bookstein JJ, Klein EW: Possible association between benign hepatomas and oral contraceptives. Lancet II: 926–929, 1973.
  • 2. Grabowski M, Stenram U, Bergqvist A: Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives and other drugs affecting the liver. Acta Pathol Microbiol Scand. Sect A 83:615–622, 1975.[Web of Science]
  • 3. Edmondson HA, Henderson B, Benton B: Liver-cell adenomas associated with the use of oral contraceptives. New Engl J Med 294: 470–472, 1976.[Abstract]
  • 4. Klatskin G: Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterol 73: 386–394, 1977.[Web of Science][Medline] [Order article via Infotrieve]
  • 5. Rooks JB, Ory HN, Ishak KG et al: Epidemiology of hepatocellular adenoma. JAMA 242:644–648, 1979.[Abstract/Free Full Text]
  • 6. Vana J, Murphy GP, Aronoff BL, Baker HW: Survey of primary liver tumors and oral contraceptive use. J Toxicol Environ Health. 3: 255–273, 1979.
  • 7. Squire RA, Levitt MH: Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res 35: 3214–3223, 1975.[Free Full Text]
  • 8. Histologic typing of liver tumors of the rat. JNCI 64:179–206, 1980.
  • 9. Committe on Safety of Medicines: Carcinogenicity tests of oral contraceptives. Her Majesty's Stationary Office, London, 1972.
  • 10. Schuppler J, Guenzel P: Cyproterone acetate. Lancet II: 688, 1976.
  • 11. Schuppler J, Guenzel P: Liver tumors and steroid hormones in rats and mice. Arch Toxicol Suppl 2: 181–195, 1979.[Medline] [Order article via Infotrieve]
  • 12. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. 21:147–343, 1979.
  • 13. Gibson JP, Newberne JW, Kuhn WL, Elsa RJ: Comparative chronic toxicity of three oral estrogens in rats. Toxicol Appl Pharmacol 11: 489–510, 1967.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 14. Schardein JL, Kaump DH, Woosley ET, Jellema MA: Long-term toxicologic and tumorigenic studies on an oral contraceptive agent in albino rats. Toxicol Appl Pharmacol 16: 10–23, 1970.[CrossRef][Medline] [Order article via Infotrieve]
  • 15. King TO, Lubansky J: Prolonged toxicity studies of a norethindrone-estrogen combination in rats. Pharmacologist 4: 176, 1962.
  • 16. McKinney GR, Weikel JH, Webb WK, Dick RG: Use of the life-table technique to estimate effects of certain steroids on probability of tumor formation in a long-term study in rats. Toxicol Appl Pharmacol 12: 68–79, 1968.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 17. Lang R, Redmann U: Non-mutagenicity of some sex hormones in the Ames' Salmonella/microsome mutagenicity test. Mutat Res 67: 361–365, 1979.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 18. Kappus H, Remmer H: Metabolic activation of norethisterone (norethindrone) to an irreversibly protein-bound derivative by rat liver microsomes. Drug Metab Disp 35: 338–344, 1975.
  • 19. Kappus H, Bolt HM: Irreversible protein binding of norethisterone (norethindrone) epoxide Steroids 27: 29–45, 1976.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 20. Kappus H, Bolt HM, Remmer H: Irreversible protein binding of metabolites of ethinylestradiol in vivo and in vitro. Steroids 22: 203–255, 1973.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 21. Bolt HM, Kappus H, Käsbohrer R: Metabolism of 17{alpha}-ethinylestradiol by human liver microsomes in vitro: aromatic hydroxylation and irreversible protein binding of metabolites. J Clin Endocrinol Metab 39: 1072–1080, 1974.[Abstract/Free Full Text]
  • 22. Schillinger E, Prior G: Irreversible Bindung von Steroiden an Lebermikrosomen. Letter, date 5.5.1977.
  • 23. Bolt HM: Structural modifications in contraceptive steroids altering their metabolism and toxicity. Arch Toxicol 39: 13–19, 1977.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 24. Bolt HM, Kappus H: Irreversible binding of ethinylestradiol metabolites to protein and nucleic acids as catalysed by rat liver microsomes and mushroom tyrosinase. J Steroid Biochem 5: 179–184, 1974.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 25. Solt D, Farber E: New principle for the analysis of chemical carcinogenesis. Nature 283: 701–703, 1976.
  • 26. Tsuda H, Lee G, Farber E: Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res 40: 1157–1164, 1980.[Abstract/Free Full Text]
  • 27. Peraino C, Fry RJ, Staffeldt E: Reduction and enhancement by phenobarbitol of hepatocarcinogenesis induced in the rat by 2-acetylanimofluorene. Cancer Res 31: 1506–1512, 1971.[Abstract/Free Full Text]
  • 28. Peraino C, Fry RJ, Staffeldt E, Christopher JP: Comparative enhancing effects of phenobarbitol, amobarbitol, diphenylhydantoin and dichlorodiphenyl-trichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res 35: 2884–2890, 1975.[Abstract/Free Full Text]
  • 29. Peraino C, Fry RJM, Staffeldt E, Christopher JP: Enhancing effects of phenobarbitone and butylated hydroxytoluene on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Food Cosmet Toxicol 15: 93–96, 1977.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 30. Neumann F, Elger W, Nishino Y, Steinbeck H: Probleme der Dosisfindung: Sexualhormone. Arzneim Forsch 27: 296–318, 1977.[Medline] [Order article via Infotrieve]
  • 31. Argus MF, Hoch-Ligeti C, Arcos JC, Conney AH: Differential effects of ß-naphthoflavone and pregnenolone-16{alpha}-carbonitrile on diethylnitrosamine-induced hepatocarcinogenesis. J Natl Cancer Inst 61: 441–449, 1978.[Web of Science][Medline] [Order article via Infotrieve]
  • 32. Taper HS: The effect of estradiol-17-phenylpropionate and estradiol benzoate on n-nitrosomorpholine induced liver carcinogenesis in ovariectomised female rats. Cancer 42: 462–467, 1978.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 33. Cameron R, Katsumi I, Ito N: Promotive effects of ethinyl estradiol in hepatocarcinogenesis by diethylnitrosamine in male rats. Gann 72: 339–340, 1981.[Web of Science][Medline] [Order article via Infotrieve]
  • 34. Yager JD, Yager R: Oral contraceptive steroids as promotors of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 40: 3680–3685, 1980.[Abstract/Free Full Text]
  • 35. Reuber MD, Firminger H: Effect of progesterone and diethylstilbestrol on hepatic carcinogenesis in A x C rats fed N-2-fluorenyldiacetamide. JNCI 29: 933–938, 1962.[Web of Science][Medline] [Order article via Infotrieve]
  • 36. Stasny J, Paschkis KE, Cantarow A, Rothenberg MS: Neoplasms in rats with 2-acetaminofluorene and sex hormones. Cancer Res 7: 356–362, 1947.[Free Full Text]
  • 37. Toh Y-C: Systemic effect of testosterone on rat liver tumor induction by n-2-fluorenylacetamide. JNCI 48: 113–118, 1972.[Web of Science][Medline] [Order article via Infotrieve]
  • 38. Cantarow A, Paschkis KE, Stasney J, Rothenberg MS: The influence of sex hormones upon the hepatic lesions produced by 2-acetaminofluorene. Cancer Res 6: 610–616, 1946.[Free Full Text]
  • 39. Schulte-Hermann R: Induction of liver growth by xenobiotic compounds and other stimuli. Crit Rev Toxicol 3: 97–186, 1974.[CrossRef]
  • 40. Schulte-Hermann R: Reactions of the liver to injury: adaption in Toxic Injury of the Liver. Farber E (editor). Marcel Decker, New York, 1979, p. 385.
  • 41. Ohde G, Schuppler J, Schulte-Hermann R, Keiger H: Proliferation of rat liver cells in preneoplastic nodules after stimulation of liver growth by xenobiotic Inducers. Arch Toxicol Suppl. 2:451–455, 1979.
  • 42. Schulte-Hermann R, Ohde G, Schuppler J, Timmermann-Trosiener I: Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promotors phenobarbitol, hexachlorocyclohexane, steroid compounds and nafenopin. Cancer Res. 41:2556–2562, 1981.[Abstract/Free Full Text]
  • 43. Schulte-Hermann R, Schuppler J, Ohde G, Timmermann-Trosiener I: Effect of tumor promotors on proliferation of putative preneoplastic cells in rat liver in Carcinogenesis, Vol 7. Hecker E (editor). Raven Press, New York, pp. 99–104.
  • 44. Ogawa K, Onoe T, Takenchi M: Spontaneous occurrence of {gamma}-glutamyl transpeptidase positive hepatocytic foci in 105-week-old Wistar and 72-week-old Fischer 344 male rats. JNCI 67: 407–412, 1981.[Web of Science][Medline] [Order article via Infotrieve]
  • 45. Weisburger JH, Williams GM: Carcinogen Testing: Current problems and new approaches. Science 214: 401–407, 1981.[Abstract/Free Full Text]
  • 46. Düsterberg B, Hümpel M, Speck U: Terminal half-lives in plasma and bioavailability of norethisterone, levornorgestrel, cyproterone acetate and gestodene in rats, beagles and monkeys. Contraception 24(6):673–683, 1981.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 47. Back DJ, Breckenridge AM, Crawford FE, Orme ML, Rowe PH, Smith E: First pass effect of norethindrone in rabbits and rats. J Pharmacol Exp Ther 207: 555–565, 1978.[Abstract/Free Full Text]
  • 48. OCs-Update on usage, safety and side effects. Population Reports A5, January 1979.
  • 49. Royal College of General Practitioners Oral Contraception Study: Further analyses of mortality in oral contraceptive users. Lancet 1:541–1207, 1981.[CrossRef][Medline] [Order article via Infotrieve]
  • 50. Edmondson HA: Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology, Section VII, Fascicle 25, AFIP, 1958.
  • 51. Chu KC, Cipriano C, Ward JM: Factors in the evaluation of 200 NCI carcinogen bioassays. J Toxicol Environ Health 8: 251–280, 1981.[Web of Science][Medline] [Order article via Infotrieve]
  • 52. Pollak H: Spontanruptur eines Leberadenoms nach langjähriger Einnahme eines Antikonzeptivums. Münch Med Wochenschr 121: 93–94, 1979.[Web of Science]
  • 53. Noble RC: The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 37: 1929–1933, 1977.[Abstract/Free Full Text]
  • 54. Reuber MD: Effect of age and testosterone on the induction of hyperplastic nodules, carcinomas and cirrhosis of the liver in rats ingesting N-2-fluorenyldiacetamide. Eur J Cancer 12: 137–141, 1976.[Web of Science][Medline] [Order article via Infotrieve]
  • 55. Sher PS, Jensen RD, Bokelman DL: Spontaneous tumors in control F 344 and Charles River-CD rats and Charles River CD-1 and B6C3HF1 mice. Toxicol Lett 11: 103–110, 1982.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 56. Epstein SS, Arnold E, Andrea T, Bass W, Bishop Y: Detection of chemical mutagens by the dominant lethal assay in the mouse. Toxicol Appl Pharmacol 23: 288–325, 1972.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • 57. Wanless IR, Medline A: Roll of estrogens as promoters of hepatic neoplasia. Lab Invest 46: 313–320, 1982.[Web of Science][Medline] [Order article via Infotrieve]
  • 58. Schuppler J, Dammé J, Schulte-Hermann R: Assay of some endogenous and synthetic sex steroids for tumor initiating activity in rat liver using the Solt-Faber system. Carcinogenesis 4:239–241, 1983.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 10, No. 2, 132-143 (1982)
DOI: 10.1177/019262338201000224
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
P. Kasper and L. Mueller
Sex-specific induction of apoptosis by cyproterone acetate in primary rat hepatocytes
Carcinogenesis, November 1, 1999; 20(11): 2185 - 2188.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
R. F. McConnell
Comparative Aspects of Contraceptive Steroids: Effects Observed In Rats
Toxicol Pathol, February 1, 1989; 17(2): 385 - 388.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Schuppler, J.
Right arrow Articles by Günzel, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Schuppler, J.
Right arrow Articles by Günzel, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?